PER 1.27% 8.0¢ percheron therapeutics limited

don't worry, page-33

  1. 13,729 Posts.
    lightbulb Created with Sketch. 1461
    Financials have nothing to do with ANP however Kynamro is going to do well and so validates the ANP pipeline of drugs..Anp Management including George T...will be meeting with the FDA...mid year and will discuss atl1102 for Ms....and to fastrack ATP
    L 1103 for Acromegaly..(orphan status).......the thing is...anytime now we could go into serious talks with a big PHARMA..
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.001(1.27%)
Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.